April 12, 2011; 76 (15) Articles
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H.L. Pellkofer, M. Krumbholz, A. Berthele, B. Hemmer, L.A. Gerdes, J. Havla, R. Bittner, M. Canis, E. Meinl, R. Hohlfeld, T. Kuempfel
First published April 11, 2011, DOI: https://doi.org/10.1212/WNL.0b013e3182152881
H.L. Pellkofer
M. Krumbholz
A. Berthele
B. Hemmer
L.A. Gerdes
J. Havla
R. Bittner
M. Canis
E. Meinl
R. Hohlfeld
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H.L. Pellkofer, M. Krumbholz, A. Berthele, B. Hemmer, L.A. Gerdes, J. Havla, R. Bittner, M. Canis, E. Meinl, R. Hohlfeld, T. Kuempfel
Neurology Apr 2011, 76 (15) 1310-1315; DOI: 10.1212/WNL.0b013e3182152881
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 76 no. 15 1310-1315
PubMed:
Print ISSN:
Online ISSN:
History:
- Received September 2, 2010
- Accepted January 3, 2011
- First Published April 11, 2011.
Copyright & Usage:
Copyright © 2011 by AAN Enterprises, Inc.
Author Disclosures
- H.L. Pellkofer, MD,
- M. Krumbholz, MD,
- A. Berthele, MD,
- B. Hemmer, MD,
- L.A. Gerdes, MD,
- J. Havla, MD,
- R. Bittner,
- M. Canis, MD,
- E. Meinl, MD,
- R. Hohlfeld, MD and
- T. Kuempfel, MD
- H.L. Pellkofer, MD,
- M. Krumbholz, MD,
- A. Berthele, MD,
- B. Hemmer, MD,
- L.A. Gerdes, MD,
- J. Havla, MD,
- R. Bittner,
- M. Canis, MD,
- E. Meinl, MD,
- R. Hohlfeld, MD and
- T. Kuempfel, MD
- From the Institute for Clinical Neuroimmunology (H.L.P., M.K., L.A.G., J.H., R.B., E.M., R.H., T.K.), Department of Neurology (H.L.P.), and Department of Otorhinolaryngology, Head and Neck Surgery (M.C.), Ludwig Maximilians University, Munich; Department of Neuroimmunology (M.K., R.B., E.M.), Max-Planck Institute for Neurobiology, Martinsried; and Department of Neurology (A.B., B.H.), Technische Universität, Munich, Germany.
- Address correspondence and reprint requests to Dr. Hannah Pellkofer, Institute of Clinical Neuroimmunology, Ludwig Maximilians University, D-81377 Munich, Germany hannah.pellkofer{at}med.uni-muenchen.de
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Aquaporin-4 antibody titration in NMO patients treated with rituximabA retrospective studyPaola Valentino, Fabiana Marnetto, Letizia Granieri et al.Neurology: Neuroimmunology & Neuroinflammation, December 15, 2016 -
Article
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis opticaChun-Sheng Yang, Li Yang, Ting Li et al.Neurology, July 24, 2013 -
Article
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorderMargherita Nosadini, Gulay Alper, Catherine J. Riney et al.Neurology - Neuroimmunology Neuroinflammation, January 21, 2016 -
Article
B-Cell Compartmental Features and Molecular Basis for Therapy in Autoimmune DiseaseChao Zhang, Tian-Xiang Zhang, Ye Liu et al.Neurology: Neuroimmunology & Neuroinflammation, August 31, 2021